MedTrace Logo

The Effect of IV Dexamethasone on the Duration of Analgesia of Spinal Anaesthesia for C-Sections at a Jamaican Hospital

NCT04624360 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-11-10

No results posted yet for this study

Summary

Dexamethasone is one of many adjuncts tested to prolong the duration of spinal anesthesia and its analgesic effect. The intent of this, a single-site, double-blinded, randomized controlled trial, is to determine if a single intravenous (IV) 8 mg dose of Dexamethasone given after clamping of the umbilical cord at Caesarean section will prolong the duration of analgesia provided by spinal anesthesia when compared to placebo. This has the power to determine if the findings in previous studies hold true in the population of women who undergo C-sections at the Victoria Jubilee Hospital. This method does not require expert skill and equipment, as such, it can be easily implemented, with no major adverse effects in the population described and provide an effective option for multimodal analgesia.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Dexamethasone

Intravenous of Dexamethasone 8 mg post clamping of the umbilical cord

OTHER

Placebo

2cc 0.9% Saline

Sponsors & Collaborators

  • National Health Fund of Jamaica

    collaborator UNKNOWN

  • The University of The West Indies

    lead OTHER

Principal Investigators

  • Christine Stephen, MB;BS, DM · University of the West Indies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-27
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Jamaica

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624360 on ClinicalTrials.gov